Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Terns Pharmaceuticals (TERN) Cash from Operations (2020 - 2023)

Terns Pharmaceuticals' Cash from Operations history spans 4 years, with the latest figure at 19316000.0 for Q4 2023.

  • For Q4 2023, Cash from Operations fell 72.3% year-over-year to 19316000.0; the TTM value through Dec 2023 reached 67390000.0, down 37.23%, while the annual FY2025 figure was 82176000.0, 17.37% down from the prior year.
  • Cash from Operations reached 19316000.0 in Q4 2023 per TERN's latest filing, up from 20699000.0 in the prior quarter.
  • In the past five years, Cash from Operations ranged from a high of 6313000.0 in Q3 2020 to a low of 20699000.0 in Q3 2023.
  • Average Cash from Operations over 4 years is 11758437.5, with a median of 11186500.0 recorded in 2022.
  • Peak YoY movement for Cash from Operations: crashed 96.46% in 2021, then increased 7.1% in 2022.
  • A 4-year view of Cash from Operations shows it stood at 7387000.0 in 2020, then tumbled by 44.43% to 10669000.0 in 2021, then decreased by 5.08% to 11211000.0 in 2022, then crashed by 72.3% to 19316000.0 in 2023.
  • Per Business Quant, the three most recent readings for TERN's Cash from Operations are 19316000.0 (Q4 2023), 20699000.0 (Q3 2023), and 12993000.0 (Q2 2023).